Literature DB >> 15772859

Incidental ovarian 18F-FDG accumulation on PET: correlation with the menstrual cycle.

Seok-Ki Kim1, Keon Wook Kang, Ju Won Roh, Jung Suk Sim, Eun Sook Lee, Sang-Yoon Park.   

Abstract

PURPOSE: The aim of this study was to determine the nature of incidental ovarian( 18)F-fluoro-2-deoxyglucose (FDG) accumulation on positron emission tomography (PET) and the correlation with the menstrual cycle and menopause.
METHODS: We identified 19 incidental FDG accumulations in the ovary (FAOs). FDG PET images were compared with other anatomical imaging methods [magnetic resonance imaging (MRI), computed tomography (CT) or ultrasonography (US)]. Pathological findings, FDG PET scan during the next menstrual cycle and follow-up images (PET, CT and MRI) were reviewed. To establish the relation of FAOs to the menstrual cycle, we reviewed whole-body FDG PET acquired from 207 consecutive women and the pre-examination questionnaires, including data regarding the menstrual cycle.
RESULTS: All spherical or discoid FAOs were attributed to normally developing ovarian follicles and corpora lutea on the basis of concurrent MRI, US or the follow-up PET scan. Three of the FAOs were proved pathologically to be either normal ovaries or a haemorrhagic corpus luteum. Fifteen FAOs spontaneously disappeared on the short-term follow-up PET scans. Of 207 women, 61 had active menstrual cycles. FAOs were found in 12 out of 61 premenopausal women (20%), appearing between the 10th and 25th days of the menstrual cycle. No FAOs were found in the women who did not have a menstrual cycle.
CONCLUSION: Physiological ovarian FDG accumulation could be found around the time of ovulation and during the early luteal phase of the menstrual cycle in premenopausal woman. Since FAO is dependent on the menstrual cycle, it can be avoided by scheduling PET just after menstruation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15772859     DOI: 10.1007/s00259-005-1771-6

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  6 in total

1.  Structure of the corpus luteum in the ovulatory polycystic ovary.

Authors:  S F Lunn; H M Fraser; H D Mason
Journal:  Hum Reprod       Date:  2002-01       Impact factor: 6.918

2.  Whole-body PET: physiological and artifactual fluorodeoxyglucose accumulations.

Authors:  H Engel; H Steinert; A Buck; T Berthold; R A Huch Böni; G K von Schulthess
Journal:  J Nucl Med       Date:  1996-03       Impact factor: 10.057

Review 3.  Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients.

Authors:  L G Strauss
Journal:  Eur J Nucl Med       Date:  1996-10

Review 4.  Normal physiological and benign pathological variants of 18-fluoro-2-deoxyglucose positron-emission tomography scanning: potential for error in interpretation.

Authors:  G J Cook; I Fogelman; M N Maisey
Journal:  Semin Nucl Med       Date:  1996-10       Impact factor: 4.446

5.  Relationship between Gastrointestinal F-18-fluorodeoxyglucose Accumulation and Gastrointestinal Symptoms in Whole-Body PET.

Authors:  Seok ki Kim; June Key Chung; Byung Tae Kim; Sun Jung Kim; Jae Min Jeong; Dong Soo Lee; Myung Chul Lee
Journal:  Clin Positron Imaging       Date:  1999-10

6.  Normal and abnormal 18F-FDG endometrial and ovarian uptake in pre- and postmenopausal patients: assessment by PET/CT.

Authors:  Hedva Lerman; Ur Metser; Dan Grisaru; Ami Fishman; Gennady Lievshitz; Einat Even-Sapir
Journal:  J Nucl Med       Date:  2004-02       Impact factor: 10.057

  6 in total
  15 in total

Review 1.  Spectrum of fluorodeoxyglucose-positron emission tomography/computed tomography and magnetic resonance imaging findings of ovarian tumors.

Authors:  Kazuhiro Kitajima; Yoshiko Ueno; Tetsuo Maeda; Koji Murakami; Yasushi Kaji; Masato Kita; Kayo Suzuki; Kazuro Sugimura
Journal:  Jpn J Radiol       Date:  2011-09-29       Impact factor: 2.374

2.  F-18 FDG PET/CT findings of metastatic ovarian tumors from gastrointestinal tract origin.

Authors:  Hye Lim Park; Ie Ryung Yoo; Joo Hyun O; Eun Ji Han; Sung Hoon Kim
Journal:  J Cancer Res Clin Oncol       Date:  2015-05-03       Impact factor: 4.553

Review 3.  An update on the role of PET/CT and PET/MRI in ovarian cancer.

Authors:  Benjapa Khiewvan; Drew A Torigian; Sahra Emamzadehfard; Koosha Paydary; Ali Salavati; Sina Houshmand; Thomas J Werner; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-02-08       Impact factor: 9.236

4.  Differential Diagnosis of Borderline Ovarian Tumors from Stage I Malignant Ovarian Tumors using FDG PET/CT.

Authors:  Chulhan Kim; Hyun Hoon Chung; So Won Oh; Keon Wook Kang; June-Key Chung; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2013-04-04

5.  Bilateral Tubo-Ovarian Abscess Mimics Ovarian Cancer on MRI and (18)F-FDG PET/CT.

Authors:  Rajan Rakheja; William Makis; Marc Hickeson
Journal:  Nucl Med Mol Imaging       Date:  2011-06-30

6.  Squamous cell carcinoma arising in an ovarian mature cystic teratoma complicating pregnancy.

Authors:  Nae-Ri Yun; Jung-Woo Park; Min-Kyung Hyun; Jee-Hyun Park; Suk-Jin Choi; Eunseop Song
Journal:  Obstet Gynecol Sci       Date:  2013-03-12

7.  F-18 fluorodeoxyglucose positron emission tomography and/or computed tomography findings of an unusual breast lymphoma case and concurrent cervical cancer: a case report.

Authors:  Nghi C Nguyen; Christopher N Hueser; Aarti Kaushik; Hussein R Farghaly; Medhat M Osman
Journal:  J Med Case Rep       Date:  2010-08-20

Review 8.  Present and future role of FDG-PET/CT imaging in the management of gynecologic malignancies.

Authors:  Kazuhiro Kitajima; Yasuhiko Ebina; Kazuro Sugimura
Journal:  Jpn J Radiol       Date:  2014-04-18       Impact factor: 2.374

Review 9.  Novel imaging modalities in gynecologic cancer.

Authors:  Rebecca A Brooks; Matthew A Powell
Journal:  Curr Oncol Rep       Date:  2009-11       Impact factor: 5.075

Review 10.  PET/CT and cross sectional imaging of gynecologic malignancy.

Authors:  Revathy B Iyer; Aparna Balachandran; Catherine E Devine
Journal:  Cancer Imaging       Date:  2007-10-01       Impact factor: 3.909

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.